WAY-214156

WAY-214156 is a drug that acts as a selective, nonsteroidal agonist at the progesterone receptor. It has been researched for potential use in the treatment of breast cancer and endometriosis, but has not been approved for medical use.

Pharmacology

WAY-214156 is a selective, nonsteroidal agonist at the progesterone receptor. This means it binds to and activates the progesterone receptor, mimicking the effects of the natural hormone progesterone.

Potential Medical Uses

Research has suggested that WAY-214156 may have potential use in the treatment of breast cancer and endometriosis.

Breast Cancer

In breast cancer, WAY-214156 may work by inhibiting the growth of cancer cells. Progesterone receptors are often present in breast cancer cells, and activation of these receptors can slow the growth of the cancer.

Endometriosis

In endometriosis, WAY-214156 may work by reducing the growth of endometrial tissue outside the uterus. Progesterone is normally involved in regulating the growth of endometrial tissue, and activation of the progesterone receptor can help to control this growth.

Development Status

WAY-214156 has been researched for potential medical use, but as of now, it has not been approved for use in humans. Further research is needed to determine its safety and effectiveness.

See Also

• Progesterone receptor
• Breast cancer
• Endometriosis

WAY-214156 Resources
Latest articles Most recent articles Ongoing trials	Wikipedia